Compare Lustrum:BrightPath Biotherapeutics Co., Ltd.:4594

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index BrightPath Biotherapeutics Co., Ltd. 4594 Medicals 東証グロース March 1, 2000 2015.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

BrightPath Biotherapeutics Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2023年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2022年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2021年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2020年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents
(Percent)
1,531down
(90.0%)up
2,305down
(83.2%)down
3,265up
(87.1%)up
3,018down
(86.9%)down
4,901
(92.4%)
Other Current AssetsHelp
(Percent)
120down
(7.1%)down
391up
(14.1%)up
386up
(10.3%)up
310up
(8.9%)up
260
(4.9%)
Tangible Fixed AssetsHelp
(Percent)
0
-
25down
(0.9%)down
48down
(1.3%)down
97up
(2.8%)up
91
(1.7%)
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0
-
0
-
0
-
Investments and OthersHelp
(Percent)
50
(3.0%)up
50down
(1.8%)up
50up
(1.3%)down
49down
(1.4%)up
52
(1.0%)
Total AssetsHelp
(Percent)
1,701
(100%)
2,771
(100%)
3,749
(100%)
3,475
(100%)
5,304
(100%)
Total Current LiabilitiesHelp
(Percent)
134down
(7.9%)down
240up
(8.7%)up
212down
(5.6%)down
239up
(6.9%)up
208
(3.9%)
Total Long-term LiabilitiesHelp
(Percent)
0
-
0
-
0
-
0
-
0
-
Shareholder's EquityHelp
(Percent)
1,568down
(92.1%)up
2,531down
(91.3%)down
3,538up
(94.4%)up
3,235down
(93.1%)down
5,096
(96.1%)
Total LiabilitiesHelp
(Percent)
1,701
(100%)
2,771
(100%)
3,749
(100%)
3,475
(100%)
5,304
(100%)

BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2023年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2022年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2021年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2020年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales
(Percent)
5
(100%)
15
(100%)
3
(100%)
11
(100%)
156
(100%)
Total Sales
(Percent)
5
(100%)
15
(100%)
3
(100%)
11
(100%)
156
(100%)
Cost of SalesHelp
(Percent)
2down
(35.9%)up
3up
(21.5%)down
1down
(45.7%)up
4down
(39.5%)down
71
(45.4%)
Other Costs and RevenueHelp 1,489down
(28,201.1%)up
1,496down
(9,711.1%)down
1,721down
(68,729.8%)up
1,865down
(16,500.9%)up
1,969
(1,264.0%)
Total CostsHelp 1,491 1,500 1,722 1,869 2,040
Net RevenueHelp 3down
(64.1%)down
12up
(78.5%)up
1down
(54.3%)down
7down
(60.5%)up
85
(54.6%)
Earnings Before TaxHelp -1,484down
(-28,101.0%)down
-1,482up
(-9,616.9%)up
-1,717up
(-68,578.8%)down
-1,860up
(-16,458.9%)down
-1,881
(-1,207.0%)
Net IncomeHelp -1,486down
(-28,137.0%)down
-1,484up
(-9,632.6%)up
-1,720up
(-68,675.5%)down
-1,858up
(-16,440.5%)down
-1,884
(-1,209.4%)
当期純利益 -1,486 -1,484 -1,720 -1,858 -1,884

BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2023年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2022年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2021年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2020年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
-1,204up
(-99.9%)down
-1,512up
(-98.9%)down
-1,770up
(-86.2%)up
-1,784down
(-94.3%)down
-1,458
(-88.7%)
Investing Cash Flow(ICF)Help
(Percent)
-2up
(-0.1%)up
-18up
(-1.1%)up
-36up
(-1.8%)up
-107up
(-5.7%)up
-185
(-11.3%)
Financing Cash FlowHelp
(Percent)
432down
(35.8%)down
569down
(37.2%)down
2,053up
(100.0%)up
9down
(0.5%)down
16
(1.0%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0
(0.0%)
0
-
-0down
(0.0%)down
0up
(0.0%)up
-0
(0.0%)
Net Increase and Decrease in Cash and Cash Equivalentsn -774up
(-64.2%)down
-960down
(-62.8%)down
247up
(12.0%)up
-1,883down
(-99.5%)down
-1,627
(-99.0%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

BrightPath Biotherapeutics Co., Ltd.

Company where related level is highHelp

CHUKYOIYAKUHIN CO.,LTD.
Chiome Bioscience Inc.
ECI,Inc.
Nxera Pharma Co., Ltd.
MIZUHO MEDY CO.,LTD.
TMS Co.,Ltd.
Otsuka Holdings Co.,Ltd.
Sanko Junyaku Co.,Ltd.
TOWA PHARMACEUTICAL CO.,LTD.
Carna Biosciences,Inc.